NYSE - Delayed Quote USD

ResMed Inc. (RMD)

Compare
238.86 +0.11 (+0.05%)
At close: October 2 at 4:00 PM EDT
238.90 +0.04 (+0.02%)
Pre-Market: 8:42 AM EDT
Loading Chart for RMD
DELL
  • Previous Close 238.75
  • Open 237.20
  • Bid 231.00 x 1800
  • Ask 251.47 x 900
  • Day's Range 234.89 - 239.88
  • 52 Week Range 132.24 - 255.18
  • Volume 874,938
  • Avg. Volume 1,007,631
  • Market Cap (intraday) 35.096B
  • Beta (5Y Monthly) 0.69
  • PE Ratio (TTM) 34.47
  • EPS (TTM) 6.93
  • Earnings Date Oct 24, 2024 - Oct 28, 2024
  • Forward Dividend & Yield 2.12 (0.89%)
  • Ex-Dividend Date Aug 15, 2024
  • 1y Target Est 237.93

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

www.resmed.com

9,980

Full Time Employees

June 30

Fiscal Year Ends

Recent News: RMD

View More

Performance Overview: RMD

Trailing total returns as of 10/2/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RMD
39.85%
S&P 500
19.70%

1-Year Return

RMD
63.21%
S&P 500
33.15%

3-Year Return

RMD
6.48%
S&P 500
31.04%

5-Year Return

RMD
86.63%
S&P 500
94.19%

Compare To: RMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RMD

View More

Valuation Measures

Annual
As of 10/2/2024
  • Market Cap

    35.10B

  • Enterprise Value

    35.73B

  • Trailing P/E

    34.52

  • Forward P/E

    26.81

  • PEG Ratio (5yr expected)

    2.00

  • Price/Sales (ttm)

    7.52

  • Price/Book (mrq)

    7.22

  • Enterprise Value/Revenue

    7.63

  • Enterprise Value/EBITDA

    23.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.79%

  • Return on Assets (ttm)

    12.70%

  • Return on Equity (ttm)

    22.70%

  • Revenue (ttm)

    4.69B

  • Net Income Avi to Common (ttm)

    1.02B

  • Diluted EPS (ttm)

    6.93

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    238.36M

  • Total Debt/Equity (mrq)

    17.97%

  • Levered Free Cash Flow (ttm)

    1.18B

Research Analysis: RMD

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 1.22B
Earnings 292.24M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

180.00 Low
237.93 Average
238.86 Current
280.00 High
 

Company Insights: RMD

Research Reports: RMD

View More
  • Lowering target price to $251.00

    RESMED INC has an Investment Rating of HOLD; a target price of $251.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • Lowering target price to $263.00

    RESMED INC has an Investment Rating of HOLD; a target price of $263.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Price Target
     
  • Raising target price to $266.00

    RESMED INC has an Investment Rating of HOLD; a target price of $266.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Price Target
     
  • ResMed Earnings: Solid Result With Strong Mask Sales and Gross Margin Expansion

    ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

    Rating
    Price Target
     

People Also Watch